Cargando…

Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice

SARS-CoV-2 continues to circulate in the human population necessitating regular booster immunization for its long-term control. Ideally, vaccines should ideally not only protect against symptomatic disease, but also prevent transmission via asymptomatic shedding and cover existing and future variant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horvath, Dennis, Temperton, Nigel, Mayora-Neto, Martin, Da Costa, Kelly, Cantoni, Diego, Horlacher, Reinhold, Günther, Armin, Brosig, Alexander, Morath, Jenny, Jakobs, Barbara, Groettrup, Marcus, Hoschuetzky, Heinz, Rohayem, Jacques, ter Meulen, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029786/ https://www.ncbi.nlm.nih.gov/pubmed/36944687 http://dx.doi.org/10.1038/s41598-023-31198-3

Ejemplares similares

PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
por: Koerner, Julia, et al.
Publicado: (2021)

The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021)

Single Cell Transcriptomes, Lineage, and Differentiation of Functional Airway Microfold Cells
por: Surve, Manalee V., et al.
Publicado: (2023)

MyD88 Mediates Colitis- and RANKL-Induced Microfold Cell Differentiation
por: Li, Yang, et al.
Publicado: (2021)

The Ets Transcription Factor Spi-B Is Essential for the Differentiation of Intestinal Microfold (M) Cells
por: Kanaya, Takashi, et al.
Publicado: (2012)

The Roles of Peyer's Patches and Microfold Cells in the Gut Immune System: Relevance to Autoimmune Diseases
por: Kobayashi, Nobuhide, et al.
Publicado: (2019)

Identification of scavenger receptor B1 as the airway microfold cell receptor for Mycobacterium tuberculosis
por: Khan, Haaris S, et al.
Publicado: (2020)

Development of Functional Microfold (M) Cells from Intestinal Stem Cells in Primary Human Enteroids
por: Rouch, Joshua D., et al.
Publicado: (2016)

Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue
por: Roy, Upal, et al.
Publicado: (2015)

Polycomb Repressive Complex 2 Regulates Genes Necessary for Intestinal Microfold Cell (M Cell) Development
por: George, Joel Johnson, et al.
Publicado: (2021)

PRC2 Regulated Atoh8 Is a Regulator of Intestinal Microfold Cell (M Cell) Differentiation
por: George, Joel Johnson, et al.
Publicado: (2021)

Immune Responses Induced by Recombinant Bacillus subtilis Expressing the PEDV Spike Protein Targeted at Microfold Cells
por: Lin, Jian, et al.
Publicado: (2022)

3D morphable systems via deterministic microfolding for vibrational sensing, robotic implants, and reconfigurable telecommunication
por: Zhang, Lin, et al.
Publicado: (2022)

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
por: Mao, Tianyang, et al.
Publicado: (2022)

Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer’s disease mouse model
por: Kim, Namkwon, et al.
Publicado: (2023)

ONECUT2 regulates RANKL-dependent enterocyte and microfold cell differentiation in the small intestine; a multi-omics study
por: Luna Velez, Maria V, et al.
Publicado: (2023)

Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms
por: Cantoni, Diego, et al.
Publicado: (2022)

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
por: An, Xingyue, et al.
Publicado: (2021)

Using 3D gastrointestinal tract in vitro models with microfold cells and mucus secreting ability to assess the hazard of copper oxide nanomaterials
por: Ude, Victor C., et al.
Publicado: (2019)

Oral recombinant Lactobacillus vaccine targeting the intestinal microfold cells and dendritic cells for delivering the core neutralizing epitope of porcine epidemic diarrhea virus
por: Ma, Sunting, et al.
Publicado: (2018)

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine
por: Ainai, Akira, et al.
Publicado: (2020)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis
por: Greiff, Lennart, et al.
Publicado: (2012)

Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice
por: Barroso, Shana P. C., et al.
Publicado: (2015)

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature
por: Cantoni, Diego, et al.
Publicado: (2023)

Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)—Mediated Anti-tumor Therapy
por: Koerner, Julia, et al.
Publicado: (2019)

Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8(+) T cell responses
por: Si, Youhui, et al.
Publicado: (2018)

Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A
por: Lu, Hailing, et al.
Publicado: (2020)

Fusion-Expressed CTB Improves Both Systemic and Mucosal T-Cell Responses Elicited by an Intranasal DNA Priming/Intramuscular Recombinant Vaccinia Boosting Regimen
por: Qiu, Sugan, et al.
Publicado: (2014)

Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2
por: Li, Letian, et al.
Publicado: (2021)

Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice
por: Hu, Mary C., et al.
Publicado: (2007)

Intranasal Protollin Formulated Recombinant SARS-CoV S Protein Elicits Respiratory and Serum Neutralizing Antibodies
por: Barnard, Dale, et al.
Publicado: (2007)

Intranasal Administration of Codium fragile Polysaccharide Elicits Anti-Cancer Immunity against Lewis Lung Carcinoma
por: Wang, Yuhua, et al.
Publicado: (2021)

A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
por: Albershardt, Tina C, et al.
Publicado: (2014)

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors
por: Albershardt, Tina C., et al.
Publicado: (2020)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
por: Arias, Mauricio A., et al.
Publicado: (2012)

Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9
por: Tursi, Sarah A., et al.
Publicado: (2017)

Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post–COVID-19 Convalescent Samples
por: Shrwani, Khalid, et al.
Publicado: (2021)

Intratumoral injections of G100 (synthetic TLR4 agonist) increase trafficking of lentiviral vector-induced antigen-specific CD8 T cells to the tumor microenvironment
por: Albershardt, Tina C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jinlbpv0nnvvnhnou3rpbu0elf